Advances in Movement Disorders: The 11th Annual NYC Movement Disorder CME Symposium

Sunday, May 22, 2022, 7:00 AM - 3:00 PM, 1470 Madison Avenue, New York, NY


This symposium will provide clinicians with a comprehensive review of cuttingedge practices in the diagnosis and management of movement disorders. A broad spectrum of diseases including Parkinson disease, dystonia, tics and Tourette syndrome, tremor, and functional movement disorders will be addressed. Through didactic lecture and video review attendees will learn about current medical and cutting-edge diagnostic and management strategies including chemodenervation and surgical interventions (deep brain stimulation and MRI-guided focused ultrasound). The program will offer learners a compendium of information that will better enable them to practice clinical neurology in 2022 and beyond.

1. Discuss management options for dystonia including local injections of botulinum toxin and deep brain stimulation (DBS).
2. Discuss the efficacy of treatments for tics and Tourette syndrome and the risks associated with their use.
3. Devise an appropriate management strategy for a patient with motor symptoms of Parkinson disease.
4. Describe an appropriate movement disorder candidate for DBS (deep brain stimulation) or MRI-guided high intensity focused ultrasound.
5. Explain the current understanding of functional movement disorders and their management.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (6.00 hours), Non-Physician Attendance (6.00 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

Icahn School of Medicine at Mount Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Sunday, May 22, 2022